Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
Abstract In a recent Nature elegant study, Wang et al. identified CD300ld, a novel functionally highly conserved tumor immunosuppressive receptor, highly expressed specifically on polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSCs), as well as a key receptor in the regulation of recruitme...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2024-07-01
|
| Saila: | MedComm |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/mco2.607 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|